Chul Ahn|Daniel Ahn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Chul Ahn

Daniel Ahn

Showing results (591-600 of 593) with videos related to

Pageof 60

Sort By:

You have reached the last page of results.This site can display upto 593 results.

The New England Journal of Medicine|January 18, 2023

Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic CholangiocarcinomaLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.

The Oncologist|September 19, 2025

First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective studyIoannis Kournoutas, Paulina Marell, Jennifer Gile, et al.

Science (New York, N.Y.)|March 9, 2023

Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenaseKevin G Hicks, Ahmad A Cluntun, Heidi L Schubert, et al.

Pageof 60

Search research articles

Showing results (591-600 of 593) with videos related to

Sort By:

Pageof 60

You have reached the last page of results.This site can display upto 593 results.

The New England Journal of Medicine|January 18, 2023

Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic CholangiocarcinomaLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.

The Oncologist|September 19, 2025

Science (New York, N.Y.)|March 9, 2023

Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenaseKevin G Hicks, Ahmad A Cluntun, Heidi L Schubert, et al.

Pageof 60